JG Kuiper

Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients

JG Kuiper, Daniëlle A.M. Heideman, Erik Thunnissen et al. · Lung Cancer · 2014 · 208 citations

Medicine, Genetics, Oncology +10

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment

JG Kuiper, Sayed M.S. Hashemi, Erik Thunnissen et al. · British Journal of Cancer · 2016 · 73 citations · Full text

Medicine, Molecular Medicine, Oncology +16

High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases—One with a remarkable thoracic response as well

JG Kuiper, Egbert F. Smit · Lung Cancer · 2013 · 46 citations

Medicine, Oncology, Pharmacology +11

VeriStrat® has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib

JG Kuiper, Joline S.W. Lind, Harry J.M. Groen et al. · British Journal of Cancer · 2012 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

Anthonie J. van der Wekken, JG Kuiper, Ali Saber et al. · PLoS ONE · 2017 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17